NASDAQ:XENE

Xenon Pharmaceuticals Stock Forecast

etoro logo Buy XENE
*Your capital is at risk
$51.73
-1.26 (-2.38%)
At Close: Jun 05, 2026
AI Analysis AI Analysis of XENE AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add XENE to Watchlist?
Some Reasons Why To Add XENE:
  • Low bankruptcy risk (Altman Z-Score: 48.85)
  • +63.5% price growth over the last year
  • Lower volatility than the market (beta 0.63)
PDF

Xenon Pharmaceuticals Inc. stock price down 2.38% on Friday
(Updated on Jun 05, 2026)

Sell candidate since Jun 04, 2026 Loss -2.38%

The Xenon Pharmaceuticals Inc. stock price fell by -2.38% on the last day (Friday, 5th Jun 2026) from $52.99 to $51.73. During the last trading day the stock fluctuated 3.96% from a day low at $51.53 to a day high of $53.57. The price has fallen in 7 of the last 10 days and is down by -4.42% for this period. Volume has increased on the last day by 311 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $86.74 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -3.68% during the next 3 months and, with a 90% probability hold a price between $38.17 and $58.26 at the end of this 3-month period.

XENE Signals & Forecast

There are few to no technical positive signals at the moment. The Xenon Pharmaceuticals Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $53.34 and $55.21. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, March 09, 2026, and so far it has fallen -17.57%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Xenon Pharmaceuticals Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $41.94. With no support from accumulated volume below today's level the risk is increased, as a drop below the support at $ may give a huge drop in the stock price.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $2.04 (3.96%) between high and low. For the last week, the stock has had daily average volatility of 3.65%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (XENE) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Xenon Pharmaceuticals Inc. to open at $52.28, and during the day (based on 14 day Average True Range), to move between $50.85 and $52.61, which gives a possible trading interval of +/-$1.76 (+/-3.46%) up or down from last closing price. If Xenon Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 3.46% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $59.04 (14.13%) than the support at $41.94 (18.93%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Xenon Pharmaceuticals Inc. stock A Buy?

Xenon Pharmaceuticals Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.059 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $52.28 ( 1.06%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

XENE Performance

Trading levels for XENE

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 54.32 5.00%
R2 53.54 3.49%
R1 53.06 2.56%
Price 51.73
S1 51.50 -0.450%
S2 51.02 -1.38%
S3 50.24 -2.89%

Accumulated Volume Support & Resistance Levels

Level Price
R3 62.76 21.32%
R2 60.61 17.17%
R1 59.04 14.13%
Price 51.73
S1 41.94 -18.93%
S2 0 -
S3 0 -

FAQ

What is the symbol for Xenon Pharmaceuticals Inc. Stock and on which exchange is it traded?
The symbol for Xenon Pharmaceuticals Inc. is XENE and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Xenon Pharmaceuticals Inc. Stock?
Xenon Pharmaceuticals Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Xenon Pharmaceuticals Inc. Stock?
Xenon Pharmaceuticals Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Xenon Pharmaceuticals Inc. Stock.

What's the current price of Xenon Pharmaceuticals Inc. Stock?
As of the end of day on the Jun 05, 2026, the price of an Xenon Pharmaceuticals Inc. (XENE) share was $51.73.

What is the 52-week high and low for Xenon Pharmaceuticals Inc. Stock?
The 52-week high for Xenon Pharmaceuticals Inc. Stock is $63.95 and the 52-week low is $30.00.

What is the market capitalization of Xenon Pharmaceuticals Inc. Stock?
As of the Jun 05, 2026, the market capitalization of Xenon Pharmaceuticals Inc. is 4.084B.

When is the next earnings date for Xenon Pharmaceuticals Inc.?
The upcoming earnings date for Xenon Pharmaceuticals Inc. is Aug 10, 2026.
Click to get the best stock tips daily for free!
ABOUT XENON PHARMACEUTICALS INC.
Xenon Pharmaceuticals
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopathy; and XEN1101, A Kv7 potassium channel opener, which is in Phase II clinical trial for the treatment o...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
4.09% May 06
GLBE
$31.61
1.65% May 05
FIZZ
$34.11
7.04% May 01
ADBE
$243.57
3.23% Apr 29
W
WCLD
$27.34
17.78% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE